RYBELSUS 7 MG COM OR CT BL AL AL X 90

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1176600370080
  • GGREM 526620120008907
  • Código de barras 7897705202739

O que a fonte publica

Detentor do registro
NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA
Princípios ativos
SEMAGLUTIDA
Embalagem
7 MG COM OR CT BL AL AL X 90
Tipo de produto
Biológico
Classe terapêutica
A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:526620120008907
{
  "name": "RYBELSUS 7 MG COM OR CT BL AL AL X 90",
  "holder": "NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA",
  "stripe": null,
  "barcodes": [
    "7897705202739"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "526620120008907",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "82.277.955/0001-55",
  "priceRegime": "Regulado",
  "productName": "RYBELSUS",
  "productType": "Biológico",
  "hospitalOnly": false,
  "presentation": "7 MG COM OR CT BL AL AL X 90",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "2582.55",
    "icms-12": "2934.72",
    "icms-17": "3111.51",
    "icms-18": "3149.45",
    "icms-19": "3188.33",
    "icms-20": "3228.19",
    "icms-21": "3269.05",
    "icms-22": "3310.96",
    "icms-23": "3353.96",
    "icms-17.5": "3130.36",
    "icms-19.5": "3208.14",
    "icms-20.5": "3248.49",
    "icms-22.5": "3332.32",
    "icms-12-alc": "2620.28",
    "icms-17-alc": "2778.13",
    "icms-18-alc": "2812.01",
    "icms-19-alc": "2846.72",
    "icms-20-alc": "2882.31",
    "icms-21-alc": "2918.80",
    "icms-22-alc": "2956.21",
    "icms-23-alc": "2994.61",
    "withoutTaxes": "2305.85",
    "icms-17.5-alc": "2794.97",
    "icms-19.5-alc": "2864.41",
    "icms-20.5-alc": "2900.44",
    "icms-22.5-alc": "2975.29"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "SEMAGLUTIDA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "3464.40",
    "icms-12": "3936.82",
    "icms-17": "4173.98",
    "icms-18": "4224.88",
    "icms-19": "4277.03",
    "icms-20": "4330.50",
    "icms-21": "4385.31",
    "icms-22": "4441.53",
    "icms-23": "4499.22",
    "icms-17.5": "4199.27",
    "icms-19.5": "4303.61",
    "icms-20.5": "4357.73",
    "icms-22.5": "4470.19",
    "icms-12-alc": "3622.38",
    "icms-17-alc": "3840.60",
    "icms-18-alc": "3887.44",
    "icms-19-alc": "3935.42",
    "icms-20-alc": "3984.62",
    "icms-21-alc": "4035.07",
    "icms-22-alc": "4086.79",
    "icms-23-alc": "4139.87",
    "withoutTaxes": "3187.70",
    "icms-17.5-alc": "3863.88",
    "icms-19.5-alc": "3959.88",
    "icms-20.5-alc": "4009.69",
    "icms-22.5-alc": "4113.16"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "SEMAGLUTIDA"
  ],
  "therapeuticClass": "A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1176600370080",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "A10S",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:526620120008907"